Clinical Trials: Lung tumor trial
As part of our ongoing commitment to clinical research, PetCure Oncology is launching a clinical trial to evaluate stereotactic radiosurgery (SRS) in the treatment of primary lung tumors in dogs.
Prior to the emergence of SRS, surgery was the primary treatment option for dogs diagnosed with lung tumors. But SRS has changed the way we approach cancer care for pets, offering noninvasive therapy with unprecedented precision that, in many cases, enables the treatment of tumors previously considered “untreatable.” If your pet has been diagnosed with a lung tumor, there may be hope. Studies have shown SRS to be successful in the treatment of lung tumors in humans. This study is intended to prove the hypothesis that dogs can also be safely and effectively treated for lung tumors with SRS.
If your dog has been diagnosed with a primary lung tumor, or if you are a veterinarian with a canine patient that has been diagnosed with one, they may be eligible for subsidized SRS treatment through this clinical trial.
Email ClinicalTrials@PetCureOncology.com if you have more questions or would like to submit an application.